INTERNATIONAL PATENT: GUANGZHOU MEDICAL UNIVERSITY, 广州医科大学 FILES APPLICATION FOR "SHRNA FOR REVERSING EGFR-TKI DRUG RESISTANCE IN NON-SMALL CELL LUNG CANCER AND USE THEREOF"

GENEVA, April 26 -- GUANGZHOU MEDICAL UNIVERSITY (No.1 Xinzao Road, Xinzao Town, Panyu DistrictGuangzhou, Guangdong 511400), 广州医科大学 (中国广东省广州市番禺区新造镇新造路1号) filed a patent application (PCT/CN2024/125271) for "SHRNA FOR REVERSING EGFR-TKI DRUG RESISTANCE IN NON-SMALL CELL LUNG CANCER AND USE THEREOF" on Oct 16, 2024. With publication no. WO/2026/081120, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Pro...